









Markets
/
Stocks
/
nasdaq-are
/

Alexandria Real Estate Equities Inc

ARE



View Detailed Chart

47.960USD

-0.990-2.02%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

8.17BMarket Cap

LossP/E TTM



Alexandria Real Estate Equities Inc

47.960

-0.990-2.02%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

-2.02%

5 Days

+2.83%

1 Month

-1.84%

6 Months

-32.80%

Year to Date

-50.84%

1 Year

-51.64%

View Detailed Chart

TradingKey Stock Score of Alexandria Real Estate Equities Inc

Currency: USD Updated: 2025-12-19

Key Insights

Alexandria Real Estate Equities Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73/196 in the Residential & Commercial REITs industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 68.85.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alexandria Real Estate Equities Inc's Score

Industry at a Glance

Industry Ranking

73 / 196

Overall Ranking

151 / 4582

Industry

Residential & Commercial REITs

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 15 analysts

Hold

Current Rating

68.846

Target Price

+53.09%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Alexandria Real Estate Equities Inc Highlights

StrengthsRisks

Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 21.14% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 293.00%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 293.00%.

Undervalued

The company’s latest PE is -19.41, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 169.52M shares, increasing 0.02% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 1.13K shares of this stock.